Activation of the HGF/c-MET axis promotes lenvatinib resistance in hepatocellular carcinoma cells with high c-MET expression
Rongdang Fu, Shaotao Jiang, Jieyuan Li, Huanwei Chen, Xiaohong Zhang
Topics & Concepts
LenvatinibHepatocellular carcinomaHematologyInternal medicineOncologyMedicineCancer researchCarcinomaSorafenibLiver physiology and pathologyHepatocellular Carcinoma Treatment and PrognosisCancer Mechanisms and Therapy